Metabolic syndrome in rheumatoid arthritis patients: Relationship among its clinical components.
Mariel García-ChagollánSusana Elizabeth Hernández-MartínezAlma Elizabeth Rojas-RomeroJosé Francisco Munoz-ValleRamón Sigala-ArellanoSergio Cerpa-CruzJosé Javier Morales-NúñezJosé Alvaro Lomelí-NietoGabriela Macedo-OjedaJorge Hernández-BelloPublished in: Journal of clinical laboratory analysis (2020)
The MetS prevalence in RA patients from western Mexico is not higher than controls; however, in RA patients with MetS, some inflammatory markers are associated with MetS components; thus, the control of MetS in RA could be beneficial to regulate disease activity.
Keyphrases
- disease activity
- rheumatoid arthritis patients
- rheumatoid arthritis
- systemic lupus erythematosus
- ankylosing spondylitis
- metabolic syndrome
- juvenile idiopathic arthritis
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- risk factors
- prognostic factors
- insulin resistance
- peritoneal dialysis
- cardiovascular disease
- uric acid
- patient reported outcomes
- patient reported